サインイン 無料でサインアップします。

Last updated: 1 July 2024 at 6:24pm EST

Richard Levy Net Worth




The estimated Net Worth of Richard S Levy is at least 4.23 百万$ dollars as of 5 June 2024. Richard Levy owns over 4,373 units of Madrigal Pharmaceuticals Inc stock worth over 3,005,001$ and over the last 16 years he sold MDGL stock worth over 559,130$. In addition, he makes 662,500$ as Independent Director at Madrigal Pharmaceuticals Inc.

Richard Levy MDGL stock SEC Form 4 insiders trading

Richard has made over 44 trades of the Madrigal Pharmaceuticals Inc stock since 2010, according to the Form 4 filled with the SEC. Most recently he exercised 4,373 units of MDGL stock worth 1,018,909$ on 5 June 2024.

The largest trade he's ever made was exercising 231,096 units of Madrigal Pharmaceuticals Inc stock on 13 February 2014 worth over 2,029,023$. On average, Richard trades about 11,032 units every 63 days since 2009. As of 5 June 2024 he still owns at least 12,897 units of Madrigal Pharmaceuticals Inc stock.

You can see the complete history of Richard Levy stock trades at the bottom of the page.





Richard Levy biography

Dr. Richard S. Levy M.D. serves as Independent Director of the Company. Dr. Levy has served on Madrigal’s board of directors since August of 2016. Dr. Levy also serves on the board of directors of Artara Therapeutics, Inc., Kodiak Sciences Inc., and Kiniksa Pharmaceuticals, Ltd., each a publicly-held pharmaceutical company. Dr. Levy previously served on the board of Aquinox Pharmaceuticals, Inc. Previously, from December 2016 to May 2019, Dr. Levy was a part-time Senior Advisor for Baker Bros. Advisors, L.P., a firm that primarily manages long-term investment funds focused on publicly traded life sciences companies. Dr. Levy served as Executive Vice President and Chief Drug Development Officer at Incyte from January 2009 until his retirement in April 2016, and as Senior Vice President of Drug Development at Incyte from August 2003 to January 2009. Prior to joining Incyte, Dr. Levy served as Vice President, Biologic Therapies, at Celgene Corporation, a publicly-held biopharmaceutical company, from 2002 to 2003. From 1997 to 2002, Dr. Levy served in various executive positions with DuPont Pharmaceuticals Company, first as Vice President, Regulatory Affairs and Pharmacovigilence, and thereafter as Vice President, Medical and Commercial Strategy. Dr. Levy served at Novartis, and its predecessor company Sandoz, from 1991 to 1997 in positions of increasing responsibility in clinical research and regulatory affairs. Dr. Levy has more than 25 years’ experience in the pharmaceutical and biotechnology industries through his prior positions at Incyte, Celgene, DuPont Pharmaceuticals and Novartis, has extensive clinical research, regulatory and product development skills and has worked in multiple therapeutic areas. Prior to joining the pharmaceutical industry, Dr. Levy served as an Assistant Professor of Medicine at the UCLA School of Medicine. Dr. Levy is Board Certified in Internal Medicine and Gastroenterology and received his A.B. in Biology from Brown University, his M.D. from the University of Pennsylvania School of M

What is the salary of Richard Levy?

As the Independent Director of Madrigal Pharmaceuticals Inc, the total compensation of Richard Levy at Madrigal Pharmaceuticals Inc is 662,500$. There are 11 executives at Madrigal Pharmaceuticals Inc getting paid more, with Paul Friedman having the highest compensation of 6,093,190$.



How old is Richard Levy?

Richard Levy is 62, he's been the Independent Director of Madrigal Pharmaceuticals Inc since 2016. There are 8 older and 9 younger executives at Madrigal Pharmaceuticals Inc. The oldest executive at Madrigal Pharmaceuticals Inc is David Milligan, 79, who is the Independent Director.

What's Richard Levy's mailing address?

Richard's mailing address filed with the SEC is 1200 PAGE MILL ROAD, , PALO ALTO, CA, 94304.

Insiders trading at Madrigal Pharmaceuticals Inc

Over the last 8 years, insiders at Madrigal Pharmaceuticals Inc have traded over 471,222,585$ worth of Madrigal Pharmaceuticals Inc stock and bought 443,785 units worth 79,114,183$ . The most active insiders traders include Bros. Advisors Lp667, L.P.B...、Paul A Friedman、Bros. Advisors Lp667, L.P.B.... On average, Madrigal Pharmaceuticals Inc executives and independent directors trade stock every 56 days with the average trade being worth of 20,602,093$. The most recent stock trade was executed by William John Sibold on 9 September 2024, trading 6,363 units of MDGL stock currently worth 1,551,490$.



What does Madrigal Pharmaceuticals Inc do?

madrigal pharmaceuticals inc. is a biotechnology company based out of calle laguna del marquesado nª 19, nave 16 edificio adriana 1ª planta, polígono industrial la resina (villaverde), madrid, community of madrid, spain.



What does Madrigal Pharmaceuticals Inc's logo look like?

Madrigal Pharmaceuticals Inc logo

Complete history of Richard Levy stock trades at Incyte、Madrigal Pharmaceuticals Inc、Kiniksa Pharmaceuticals International Plc、Constellation Pharmaceuticals Inc、Kodiak Sciences Inc、Protara Therapeutics Inc

日付
#
会社
 インサイダー
取引
取引
 株式 1株当たりの株価 合計金額 その後の株式数 ソース
5 Jun 2024 KNSA Kiniksa Pharmaceuticals International Plc. Richard S Levy
オプション行使 4,373 19.71$ 86,192$
5 Jun 2024
12,897 ↗
3 May 2024 KNSA Kiniksa Pharmaceuticals International Plc. Richard S Levy
オプション行使 747 20.08$ 15,000$
3 May 2024
8,524 ↗
3 Nov 2023 KNSA Kiniksa Pharmaceuticals International Plc. Richard S Levy
オプション行使 2,777 16.20$ 44,987$
3 Nov 2023
7,777 ↗
29 Jun 2023 KNSA Kiniksa Pharmaceuticals International Plc. Richard S Levy
オプション行使 5,000 14.35$ 71,750$
29 Jun 2023
5,000 ↗
1 Apr 2024 MDGL Madrigal Pharmaceuticals Inc Richard S Levy
オプション行使 11,000 63.92$ 703,120$
1 Apr 2024
21,298 ↗
17 Jan 2023 MDGL Madrigal Pharmaceuticals Inc Richard S Levy
オプション行使 22,489 103.02$ 2,316,817$
17 Jan 2023
31,589 ↗
23 Aug 2017 MDGL Madrigal Pharmaceuticals Inc Richard S Levy
購入する 2,000 16.12$ 32,240$
23 Aug 2017
9,100 ↗
22 Aug 2017 MDGL Madrigal Pharmaceuticals Inc Richard S Levy
購入する 3,550 16.12$ 57,226$
22 Aug 2017
7,100 ↗
21 Aug 2017 MDGL Madrigal Pharmaceuticals Inc Richard S Levy
購入する 3,550 15.88$ 56,374$
21 Aug 2017
3,550 ↗
20 Mar 2020 KOD Kodiak Sciences Inc Richard S Levy
購入する 1,000 44.33$ 44,330$
20 Mar 2020
1,000 ↗
6 Jan 2016 INCY Incyte Corp. Richard S Levy
EVP、Chief Drug Dev、Medical Of
 オプション行使 3,937 18.32$ 72,126$
6 Jan 2016
20,863 ↗
7 Dec 2015 INCY Incyte Corp. Richard S Levy
EVP、Chief Drug Dev、Medical Of
 オプション行使 3,937 18.32$ 72,126$
7 Dec 2015
20,863 ↗
6 Nov 2015 INCY Incyte Corp. Richard S Levy
EVP、Chief Drug Dev、Medical Of
 オプション行使 3,936 18.32$ 72,108$
6 Nov 2015
20,862 ↗
6 Oct 2015 INCY Incyte Corp. Richard S Levy
EVP、Chief Drug Dev、Medical Of
 オプション行使 3,937 18.32$ 72,126$
6 Oct 2015
20,863 ↗
11 Sep 2015 INCY Incyte Corp. Richard S Levy
EVP、Chief Drug Dev、Medical Of
 販売 4,301 130.00$ 559,130$
11 Sep 2015
16,926 ↗
8 Sep 2015 INCY Incyte Corp. Richard S Levy
EVP、Chief Drug Dev、Medical Of
 オプション行使 3,937 18.32$ 72,126$
8 Sep 2015
25,164 ↗
6 Aug 2015 INCY Incyte Corp. Richard S Levy
EVP、Chief Drug Dev、Medical Of
 オプション行使 3,936 18.32$ 72,108$
6 Aug 2015
25,163 ↗
15 Jul 2015 INCY Incyte Corp. Richard S Levy
EVP、Chief Drug Dev、Medical Of
 オプション行使 70,217 17.79$ 1,249,160$
15 Jul 2015
91,444 ↗
6 Jul 2015 INCY Incyte Corp. Richard S Levy
EVP、Chief Drug Dev、Medical Of
 オプション行使 3,937 18.32$ 72,126$
6 Jul 2015
25,164 ↗
19 Jun 2015 INCY Incyte Corp. Richard S Levy
EVP、Chief Drug Dev、Medical Of
 オプション行使 20,000 17.79$ 355,800$
19 Jun 2015
41,227 ↗
8 Jun 2015 INCY Incyte Corp. Richard S Levy
EVP、Chief Drug Dev、Medical Of
 オプション行使 3,937 18.32$ 72,126$
8 Jun 2015
25,164 ↗
6 May 2015 INCY Incyte Corp. Richard S Levy
EVP、Chief Drug Dev、Medical Of
 オプション行使 7,412 18.32$ 135,788$
6 May 2015
28,639 ↗
6 Apr 2015 INCY Incyte Corp. Richard S Levy
EVP、Chief Drug Dev、Medical Of
 オプション行使 25,000 18.32$ 458,000$
6 Apr 2015
46,227 ↗
6 Mar 2015 INCY Incyte Corp. Richard S Levy
EVP、Chief Drug Dev、Medical Of
 オプション行使 25,000 18.32$ 458,000$
6 Mar 2015
46,227 ↗
17 Feb 2015 INCY Incyte Corp. Richard S Levy
EVP、Chief Drug Dev、Medical Of
 オプション行使 12,000 15.66$ 187,920$
17 Feb 2015
30,205 ↗
6 Feb 2015 INCY Incyte Corp. Richard S Levy
EVP、Chief Drug Dev、Medical Of
 オプション行使 25,000 18.32$ 458,000$
6 Feb 2015
43,205 ↗
16 Jan 2015 INCY Incyte Corp. Richard S Levy
EVP、Chief Drug Dev、Medical Of
 オプション行使 12,000 14.72$ 176,640$
16 Jan 2015
30,205 ↗
6 Jan 2015 INCY Incyte Corp. Richard S Levy
EVP、Chief Drug Dev、Medical Of
 オプション行使 25,000 18.32$ 458,000$
6 Jan 2015
43,205 ↗
16 Dec 2014 INCY Incyte Corp. Richard S Levy
EVP、Chief Drug Dev、Medical Of
 オプション行使 12,000 14.72$ 176,640$
16 Dec 2014
30,205 ↗
17 Nov 2014 INCY Incyte Corp. Richard S Levy
EVP、Chief Drug Dev、Medical Of
 オプション行使 12,000 14.72$ 176,640$
17 Nov 2014
30,205 ↗
23 Oct 2014 INCY Incyte Corp. Richard S Levy
EVP、Chief Drug Dev、Medical Of
 オプション行使 13,904 3.11$ 43,241$
23 Oct 2014
18,205 ↗
16 Oct 2014 INCY Incyte Corp. Richard S Levy
EVP、Chief Drug Dev、Medical Of
 オプション行使 8,000 14.72$ 117,760$
16 Oct 2014
12,301 ↗
16 Sep 2014 INCY Incyte Corp. Richard S Levy
EVP、Chief Drug Dev、Medical Of
 オプション行使 8,000 14.72$ 117,760$
16 Sep 2014
12,301 ↗
18 Aug 2014 INCY Incyte Corp. Richard S Levy
EVP、Chief Drug Dev、Medical Of
 オプション行使 8,000 14.72$ 117,760$
18 Aug 2014
12,301 ↗
16 Jul 2014 INCY Incyte Corp. Richard S Levy
EVP、Chief Drug Dev、Medical Of
 オプション行使 8,000 14.72$ 117,760$
16 Jul 2014
12,301 ↗
16 Jun 2014 INCY Incyte Corp. Richard S Levy
EVP、Chief Drug Dev、Medical Of
 オプション行使 8,000 14.72$ 117,760$
16 Jun 2014
12,301 ↗
16 May 2014 INCY Incyte Corp. Richard S Levy
EVP、Chief Drug Dev、Medical Of
 オプション行使 8,000 14.72$ 117,760$
16 May 2014
12,301 ↗
13 Feb 2014 INCY Incyte Corp. Richard S Levy
EVP、Chief Drug Dev、Medical Of
 オプション行使 231,096 8.78$ 2,029,023$
13 Feb 2014
44,088 ↗
6 Sep 2013 INCY Incyte Corp. Richard S Levy
EVP、Chief Drug Dev、Medical Of
 オプション行使 25,000 11.98$ 299,500$
6 Sep 2013
25,000 ↗
13 May 2013 INCY Incyte Corp. Richard S Levy
EVP、Chief Drug Dev、Medical Of
 オプション行使 60,000 7.09$ 425,400$
13 May 2013
60,000 ↗
15 Feb 2013 INCY Incyte Corp. Richard S Levy
EVP、Chief Drug Dev、Medical Of
 オプション行使 98,440 6.84$ 673,330$
15 Feb 2013
98,440 ↗
27 Apr 2012 INCY Incyte Corp. Richard S Levy
EVP、Chief Drug Dev、Medical Of
 オプション行使 30,000 8.76$ 262,800$
27 Apr 2012
30,000 ↗
18 Jan 2011 INCY Incyte Corp. Richard S Levy
EVP、Chief Drug Dev、Medical Of
 オプション行使 40,310 6.70$ 270,077$
18 Jan 2011
40,310 ↗
15 Mar 2010 INCY Incyte Corp. Richard S Levy
EVP、Chief Drug Dev、Medical Of
 オプション行使 20,000 4.19$ 83,800$
15 Mar 2010
20,000 ↗


Madrigal Pharmaceuticals Inc executives and stock owners

Madrigal Pharmaceuticals Inc executives and other stock owners filed with the SEC include: